New York S 5401: Relates to the pricing of single source brand-name maintenance medication for which there is no National Average Drug Acquisition Cost pricing

Status: REFERRED TO HEALTH (as of 2022-01-05)

State: New York · Session: 2021-2022 · Bill: S 5401

Sponsors: REICHLIN-MELNICK

View New York S 5401 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.